Mesoblast (MESO) Interest Coverage Ratio (QoQ) (2018 - 2023)
Mesoblast (MESO) Interest Coverage Ratio (QoQ) (2018 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
16.36% |
| Mar 31, 2023 |
407.28% |
| Dec 31, 2022 |
-222.43% |
| Sep 30, 2022 |
-72.32% |
| Jun 30, 2022 |
3.26% |
| Mar 31, 2022 |
-7.80% |
| Dec 31, 2021 |
-2.32% |
| Sep 30, 2021 |
-58.10% |
| Jun 30, 2021 |
392.25% |
| Mar 31, 2021 |
-2,031.95% |
| Dec 31, 2020 |
-216.60% |
| Sep 30, 2020 |
-100.93% |
| Jun 30, 2020 |
109.16% |
| Mar 31, 2020 |
-1,980.28% |
| Dec 31, 2019 |
1.36% |
| Sep 30, 2019 |
-8,265.23% |
| Jun 30, 2019 |
-99.09% |
| Mar 31, 2019 |
208.44% |
| Dec 31, 2018 |
-195.74% |
| Sep 30, 2018 |
1,931.12% |
